Effects of sliding mode control antiretroviral drug on HIV-1 viral load

被引:0
|
作者
Ahmed, Musharif [1 ]
Zafar, Saad [1 ]
Saleem, Muhammad Aamer [2 ]
Zubair, Muhammad [1 ]
Qureshi, Ijaz Mansoor [3 ]
机构
[1] Riphah Int Univ, Fac Comp, Dept Software Engn & Comp Sci, Islamabad, Pakistan
[2] Hamdard Univ, Fac Engn Sci & Technol, Dept Elect Engn, Islamabad, Pakistan
[3] Air Univ, Fac Engn, Dept Elect Engn & Comp Engn, Islamabad, Pakistan
关键词
Sliding mode control; antiretroviral drug; drug therapy; HIV; AIDS; memetic computing; MATHEMATICAL-ANALYSIS; VIRUS DYNAMICS; INFECTION; THERAPY; HOST; ALGORITHM;
D O I
10.3906/elk-1906-65
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Human immunodeficiency virus (HIV) has devastating effects on human society. Researchers have proposed many models for the decay of CD 4(+) T cells, the growth of infected cells, and viral load. In this paper, four first-order nonlinear coupled differential equations have been considered. Four variables are CD 4(+) T cells, which are healthy, less infected cells, more infected cells capable of producing virus, and finally the viral load. Apart from the two drug therapies, protease inhibitor (PI) and reverse transcriptase inhibitor (RTI), which have already been considered in the literature, we have proposed antiretroviral drug (ARD) that works as sliding mode controller. We have used numerical methods to study the effect of RTI, PI, and ARD on healthy cells, infected cells, and the viral load. We have expressed our solutions in terms of log sigmoid functions and used memetic computing for the solution which is a hybridization of GA, a global optimizer, and sequential quadratic programming, a local optimizer. ARD, as a sliding mode controller, does help to improve the situation of the HIV patient, especially, in further reducing the viral load and also decreasing the infected cells which have the potential to produce virus. This helps in giving relief to the patient and an increase in life expectancy.
引用
收藏
页码:3111 / 3125
页数:15
相关论文
共 50 条
  • [1] HIV-1 DRUG RESISTANCE MUTATIONS IN ANTIRETROVIRAL TREATED THAI PATIENTS WITH LOW VIRAL LOAD
    Horthongkham, Navin
    Prasertsom, Kornkanok
    Athipunyasilp, Niracha
    Ammaranond, Palanee
    Sutthent, Ruengpung
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2019, 50 (05) : 832 - 839
  • [2] Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy
    Vettore, MV
    Schechter, M
    Melo, MF
    Boechat, LJ
    Barroso, PF
    JOURNAL OF INFECTION, 2006, 52 (04) : 290 - 293
  • [3] Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen
    Notermans, DW
    Goudsmit, J
    Danner, SA
    de Wolf, F
    Perelson, AS
    Mittler, J
    AIDS, 1998, 12 (12) : 1483 - 1490
  • [4] Changes in HIV-1, viral load trends with highly active antiretroviral therapy
    Chew, CB
    Leroi, MJ
    Workman, C
    Dwyer, CE
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (04) : 199 - 200
  • [5] Effects of schistosomiasis on susceptibility to HIV-1 infection and HIV-1 viral load at HIV-1 seroconversion: A nested case-control study
    Downs, Jennifer A.
    Dupnik, Kathryn M.
    van Dam, Govert J.
    Urassa, Mark
    Lutonja, Peter
    Kornelis, Dieuwke
    de Dood, Claudia J.
    Hoekstra, Pytsje
    Kanjala, Chifundo
    Isingo, Raphael
    Peck, Robert N.
    Lee, Myung Hee
    Corstjens, Paul L. A. M.
    Todd, Jim
    Changaiucha, John M.
    Johnson, Warren D., Jr.
    Fitzgerald, Daniel W.
    PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (09):
  • [6] Evaluation of dried blood spots for HIV-1 viral load and drug resistance genotyping in patients on antiretroviral therapy
    Rottinghaus, E. K.
    Ugbenga, R.
    Diallo, K.
    Bassey, O.
    Vedapuri, S.
    Azeez, A.
    DeVos, J.
    Wurie, I.
    Aberle-Grasse, J.
    Nkengasong, J.
    Knight, N.
    Yang, C.
    ANTIVIRAL THERAPY, 2010, 15 : A148 - A148
  • [7] Antiretroviral drug resistance in HIV-1
    George J. Hanna
    Richard T. D’Aquila
    Current Infectious Disease Reports, 1999, 1 (3) : 289 - 297
  • [8] HIV-1 Antiretroviral Drug Therapy
    Arts, Eric J.
    Hazuda, Daria J.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (04):
  • [9] Quantification of HIV-1 viral load
    Maria Gonzalez-Alba, Jose
    Rodriguez-Dominguez, Mario
    Mateos Lindemann, Maria Luisa
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 : 47 - 50
  • [10] HIV-1 viral load testing
    Clarke, JR
    McClure, MO
    JOURNAL OF INFECTION, 1999, 38 (03) : 141 - 146